JUPITER MEDICAL CENTER PARTNERS WITH ADEPTBIO, LLC FOR NEW CLINICAL TRIAL

June 6, 2012

JUPITER MEDICAL CENTER PARTNERS WITH ADEPTBIO, LLC FOR NEW CLINICAL TRIAL

JUPITER, Fla. (June 6, 2012) – Jupiter Medical Center’s (JMC) clinical research department has opened a new clinical trial called Procurement of Human Biospecimens for Known and Future Unknown Medical Research in collaboration with AdeptBio, LLC, under the leadership of Paul Garen, MD, board certified pathologist at Jupiter Medical Center.

The goal of the partnership between JMC and AdeptBio, LLC, is to coordinate the acquisition and delivery of human biospecimens efficiently, consistently and with as little impact to patient care as possible while contributing to the development of therapies for patients now and in the future.

Clinical trials that focus on research are one of the most important weapons in the fight against disease. The purpose of this trial is to collect cancer tissue samples (that are normally discarded after surgery) and data from a large number of patients and make them available to doctors and scientists for research studies. Biospecimens used for research play an integral role in the discovery of treatment options for many diseases. 

“Our partnership with bioscience firms, such as AdeptBio, LLC, allows Jupiter Medical Center to go above and beyond in clinical research and development,” said Dr. Garen. “These studies are conducted with an eye to the future, in hopes of finding safer or more effective methods to screen for, prevent, diagnose or treat a variety of diseases. For those who participate in clinical trials, they are the heroes that are helping to develop the new drugs and treatments for the future - improving care for all.”

To be eligible for participation in this clinical trial, patients must have a cancer diagnosis and be undergoing surgery. In addition, patients must:

•Be 18 years of age or older.
•Provide medical information relevant to the study in which they are participating.
•Voluntarily sign the most current informed consent and authorization form prior to any surgical specimen collections.

“We hope that researchers using the biospecimens and data will develop better treatments and tests that are more tailored for patients with cancer and other chronic diseases,” said Jeanine Secor, RN/BSN/CRCP, JMC clinical research manager.

For more information, contact Jeanine Secor at (561) 263-5791.

ABOUT ADEPTBIO, LLC
AdeptBio is a human biospecimen contract procurement organization formed through a partnership between experts in specimen procurement, contract research, biomarker discovery, diagnostics and therapeutic research and development. The company addresses the dramatically underserved needs of pharmaceutical and diagnostic research and development communities. 

ABOUT JUPITER MEDICAL CENTER
A not-for-profit 283-bed community medical center consisting of 163 private acute care hospital beds and 120 long-term care, sub-acute rehabilitation and Hospice beds, Jupiter Medical Center provides a broad range of services with specialty concentrations in orthopedics and spine, geriatrics, minimally invasive surgical procedures including robotic surgery, emergency services, cardiac services, obstetrics, cancer care and advanced diagnostics. Founded in 1979, Jupiter Medical Center is top ranked in Palm Beach County by U.S. News & World Report, and was recognized as “high performing” in five specialty areas, including cancer, ear, nose and throat, gynecology, kidney disorders, and neurology and neurosurgery. The Medical Center has approximately 1,500 team members, 520 physicians and 700 volunteers. For more information on Jupiter Medical Center, please call (561) 263-2234 or visit the website at www.jupitermed.com.

 

# # #

Press ReleasesPR 2012